U.S. Neurosurgical Holdings Inc (USNU)

U.S. Neurosurgical, Inc., a Delaware corporation, was formed in July 1993. The Company owns and operates stereotactic radiosurgery centers, utilizing the Leksell Gamma Knife technology. It currently owns and operates one Gamma Knife centers, one on the premises of Research Medical Center (RMC) in Kansas City, Missouri, and one on the premises of New York University Medical Center (NYU) in New York, New York. The Company's business strategy is to provide cost-effective approaches that allow hospitals, physicians, and patients access to Gamma Knife treatment capability, a high capital cost item. It provides the Gamma Knife to medical facilities on a 'cost per treatment' basis. The Company's business model is to own, or hold an interest in, the Gamma Knife units, and charge the medical facility, where the unit is housed and maintained, based on utilization. Its main target market is medical centers in major health care catchment areas that have physicians experienced with and dedicated to the use of the Gamma Knife. The health care industry, in general, is highly competitive.